HPV Vaccination is Cancer Prevention CME/CNE | Other | 5/18/2016 | Yes | Module 1: CME: 0.50 AMA PRA Category 1; CNE: 0.50 contact hours eligible for pharmacology credit. Module 2: CME: 0.25 AMA PRA Category 1; CNE: 0.25 contact hours eligible for pharmacology credit | 5/18/2018 | Yes | ABP, ABOG and ABFM MOC Part 2 credit | 5/18/2018 | In this 2 part activity, Dr. Rebecca Perkins, an OB/GYN, and Christine Baze, a cervical cancer survivor, discuss the diseases and cancers caused by HPV, the safety and effectiveness of HPV vaccinations, and evidenced-based ways of recommending the vaccine |
Someone You Love HPV Documentary--Indiana University Division of Continuing Medical Education | Other | 7/1/2015 | Yes | Maximum of 1.50 AMA PRA Category 1 credits, 1.5 CE credit hours for pharmacists, 1.91 contact hours for nurses. | 7/1/2017 | No | | | Documentary "Someone You Love" now available to physicians, pharmacists and nurses free of charge for Continuing Education credit. |
HPV Vaccination: Insights from States with Highest and Lowest HPV Vaccination Rates | | 11/4/2014 | Yes | Maximum of 1.0 AMA PRA Category 1 credits | | No | | | Webinar jointly presented by CSTE & NFID; Barriers to Coverage Rates, Suggestions for Improved Coverage Rates |
Adolescent Immunizations: Office Strategies | American Academy of Pediatrics | 8/13/2014 | Yes | AMA PRA Category 1 Credit(s)™ 1.00 | 8/12/2017 | No | | | This course provides strategies that pediatric offices can use to optimize their adolescent immunization efforts and improve their adolescent immunization rates. |
Children's Mercy Hospital HPV Related Oropharyngeal Cancer Grand Rounds.pdf | Academic Pediatric Association | 8/18/2016 | Yes | | | No | | | Notable head and neck surgeon, Dr. Terry Tsue, presented grand rounds on HPV-related oropharyngeal cancer at Children’s Mercy Hospital, Kansas City, MO, on August 18, 2016. The video replay is available for CE credit. |
Human Papillomavirus-Associated Cancers | American Academy of Pediatrics | 10/1/2016 | Yes | | | No | | | Investigators from the Centers for Disease Control and Prevention (CDC) reviewed data from a national registry to estimate the annual national rates of cancers attributable to human papillomavirus (HPV). |
HPV Vaccines: Updates and Clinical Perspective | MedScape | 2/28/2017 | Yes | 0.25 | 2/28/2018 | No | | | The goal of this activity is to provide perspective on the science behind recent changes to the HPV vaccine dosing schedule. Upon completion of this activity, participants will have greater competency related to applying ACIP recommendations for HPV vacc |
ACS Endorses HPV Vaccine Guidelines for Boys and Girls | American Cancer Society | 8/18/2016 | Yes | 0.25 | 8/18/2017 | No | | | The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care. |
CDC Updates Guideline Recommendations for HPV Vaccinations | Centers for Disease Control | 1/26/2017 | Yes | 0.25 | 1/26/2018 | No | | | Upon completion of this activity, participants will be able to: Interpret HPV vaccination recommendations, based on updated guidance from the ACIP |
Overcoming Gender and Socioeconomic Disparities in HPV Vaccination | MedScape | 3/29/2017 | Yes | 0.25 | 3/29/2018 | No | | | The goal of this activity is to provide perspective on the science behind recent changes to the HPV vaccine dosing schedule. Upon completion of this activity, participants will have greater competence related to identifying opportunities to decrease dispa |
The Story of HPV: Yesterday, Today, and Tomorrow | MedScape | 3/24/2017 | Yes | 1.25 | 3/24/2018 | No | | | Upon completion of this activity, participants will: Have increased knowledge regarding the: Long-term data evaluating the impact of vaccination on HPV-related disease; Timely and appropriate HPV vaccination; HPV vaccination advocacy |
Meeting Coverage: Male HPV Vaccination Rates Remain Low | | 5/16/2017 | Yes | | | No | | | In this study, data on 1,520 men who had complete information on HPV infection, vaccination, and circumcision status in the National Health and Nutrition Examination Survey, which included penile swabs that tested for 37 straings of HPV infection. |
HPV Vaccination is Cancer Prevention | Other | | Yes | 1.00 | 7/15/2018 | No | | | Recording of a webinar discussing the diseases caused by HPV, the safety and effectiveness of HPV vaccinations, rationale for the two dose schedule, effectiveness of early vaccination, evidence-based recommendations for improving HPV vaccination rates. |
Improving Immunization Delivery in Primary Care-Utah Project | Other | | No | | | Yes | ABP Part 4 MOC or ABFM MC-FP Part IV | | A 6, 9, or 12-month Improvement Project focused on improving immunization delivery for children is available for practices in Utah ONLY. Support in implementing improvement strategies will be provided through site visits and facilitating peer connections. |
HPV: Don't Wait. Vaccinate! | Other | | No | | | Yes | ABP Part 4 | | MOC project for pediatricians nationwide. Physicians will increase their 1st dose HPV vaccine rate for eligible patients aged 11-21 by 25% during the 6 month project period. |
Accelerating HPV Vaccine Uptake: What is Working and Why | National Cancer Institute (NCI) | 9/23/2014 | No | N/A | | No | | | Presents key goals and high priority research interventions to increase HPV vaccine uptake |
Five Key Steps To Improve HPV Vaccination Rates in Your Practice | National Foundation for Infectious Diseases | 12/9/2014 | No | | | No | | | 1st link in resource center. Describes types of cancer prevented by HPV vaccine, Communication Strategies, Steps for Improving Coverage Rates |
HPV Vaccine is Cancer Prevention: CDC’s Clinician Engagement Initiative | Centers for Disease Control | 6/19/2015 | No | | | No | | | The recording of the webinar “HPV Vaccine is Cancer Prevention: CDC’s Clinician Engagement Initiative” presented by Dr. Rebecca Perkins and Dr. Sharon Humiston on Friday April 30, 2015. Be cautious using YouTube videos as questionable comments appear. |
Provider Interventions to Increase HPV Vaccinations in the US: A Successful Quality Improvement Example | Cervical Cancer Free Coalition (CCFC) | | No | | | No | | | This webinar from Cervical Cancer-free NC covers the following learning objectives: (1) leave participants anxious to evaluate their HPV vaccination rates, (2) feel motivated to implement change, (3) become knowledgeable in effective processes.Alix Casler |
Understanding HPV Vaccination Successes in North Carolina | Cervical Cancer Free Coalition (CCFC) | | No | | | No | | | Dr. Noel Brewer, Jenny Myers, Beth Meadows, Dr. Melissa Gilkey, Dr. Joan Cates, and Elizabeth Hudgins. Second in the Cervical-Free Coalition webinar series and covers data from the MMWR as well as the increase in rates of HPV vaccination in NC |
An HPV Educational Session with Dr. James Conway, UW Health | National AHEC Organization | 9/22/2015 | No | | | No | | | This presentation focused on understanding the burden of HPV disease, the importance of the HPV vaccine recommendation, and communicating about the HPV vaccine. |
National Partnership on Adolescent Immunization Quality Improvement (QI) Modules | Academic Pediatric Association | 5/2/2016 | No | | | No | | | The QI modules are a set of 15-minute videos that explain key introductory concepts in QI. The examples used throughout the series relate to adolescent immunization, with a special focus on HPV vaccination. |
Improving HPV Vaccination Rate in Michigan: A Call to Action | Other | | No | | | | | | Webinar focused on increasing HPV immunization rates in state of Michigan |
HPV Vaccination Quality Improvement Projects and Implementation Science Working Together, for the Win! | Centers for Disease Control | | No | | | | | | Dr. Brian Mittman provides an introduction about Implementation Science theory and principles. Dr. Alix Casler MD, summarizes her practice’s multi-level approach to an HPV vaccine-focused QI project. Ms. Kia Redwine, Clinical Management Consultant, descri |
HPV Vaccine Recommendation Update Webinar | Centers for Disease Control | 4/3/2015 | | | | | | | Overivew of HPV Vaccines and HPV-associated cancers, 9-valent HPV vaccine trials |